tiprankstipranks
Advertisement
Advertisement

PCINSIL Stock Latest News

Insilico Medicine Secures Up to $2.5 Billion AI Drug Discovery Pact in Neuroimmune CNS Space
Private CompaniesInsilico Medicine Secures Up to $2.5 Billion AI Drug Discovery Pact in Neuroimmune CNS Space
3h ago
INSIL
Insilico Medicine – Weekly Recap
PremiumPrivate Companies
Insilico Medicine – Weekly Recap
2d ago
INSIL
Insilico Medicine Expands Cambridge Operations With Administrative Hire
PremiumPrivate Companies
Insilico Medicine Expands Cambridge Operations With Administrative Hire
3d ago
INSIL
Insilico Medicine Highlights AI-Driven Drug Discovery Focus at SuperAI Conference
PremiumPrivate Companies
Insilico Medicine Highlights AI-Driven Drug Discovery Focus at SuperAI Conference
3d ago
INSIL
AI Collaboration Strategy Highlighted in Insilico Medicine’s Drug Discovery Platform
PremiumPrivate Companies
AI Collaboration Strategy Highlighted in Insilico Medicine’s Drug Discovery Platform
4d ago
INSIL
Insilico Medicine Reports Early Clinical Progress for AI-Designed CNS Candidate
PremiumPrivate CompaniesInsilico Medicine Reports Early Clinical Progress for AI-Designed CNS Candidate
4d ago
INSIL
Insilico hits first clinical milestone with AI-designed NLRP3 inhibitor ISM8969
Premium
Private Companies
Insilico hits first clinical milestone with AI-designed NLRP3 inhibitor ISM8969
5d ago
INSIL
Insilico Medicine Leadership Featured at Morgan Stanley China Biopharma Symposium
Premium
Private Companies
Insilico Medicine Leadership Featured at Morgan Stanley China Biopharma Symposium
5d ago
INSIL
Insilico Medicine CEO to Discuss AI Drug Discovery and Out-Licensing at Morgan Stanley China Biopharma Symposium
PremiumPrivate Companies
Insilico Medicine CEO to Discuss AI Drug Discovery and Out-Licensing at Morgan Stanley China Biopharma Symposium
6d ago
INSIL
Insilico Medicine Showcases AI Drug Discovery Platform at BIO Convention
PremiumPrivate Companies
Insilico Medicine Showcases AI Drug Discovery Platform at BIO Convention
6d ago
INSIL
Insilico Medicine Highlights Scale and Maturity of AI-Designed Drug Pipeline
PremiumPrivate Companies
Insilico Medicine Highlights Scale and Maturity of AI-Designed Drug Pipeline
6d ago
INSIL
Insilico Medicine Highlights AI–Biotech Convergence With New ‘Bits to Bio’ Series
PremiumPrivate Companies
Insilico Medicine Highlights AI–Biotech Convergence With New ‘Bits to Bio’ Series
6d ago
INSIL
Insilico Medicine Advances AI Drug Discovery Strategy With New Benchmarks, Partnerships and Clinical Visibility
PremiumPrivate CompaniesInsilico Medicine Advances AI Drug Discovery Strategy With New Benchmarks, Partnerships and Clinical Visibility
9d ago
INSIL
Insilico Medicine Positions Enterprise AI as Key Opportunity for Traditional Companies
Premium
Private Companies
Insilico Medicine Positions Enterprise AI as Key Opportunity for Traditional Companies
9d ago
INSIL
Insilico Medicine Highlights Strategic Themes in AI-Driven Drug Discovery
Premium
Private Companies
Insilico Medicine Highlights Strategic Themes in AI-Driven Drug Discovery
10d ago
INSIL
Insilico Medicine Targets Partnerships and Visibility at BIO 2026 Convention
PremiumPrivate Companies
Insilico Medicine Targets Partnerships and Visibility at BIO 2026 Convention
11d ago
INSIL
Insilico Medicine Highlights Limits of GPT 5.5 Gains for Real-World Drug Discovery
PremiumPrivate Companies
Insilico Medicine Highlights Limits of GPT 5.5 Gains for Real-World Drug Discovery
11d ago
INSIL
Insilico Medicine Expands Business Development Leadership in AI-Driven Drug Discovery
PremiumPrivate Companies
Insilico Medicine Expands Business Development Leadership in AI-Driven Drug Discovery
12d ago
INSIL
Insilico Medicine Draws Expert Interest in AI-Driven Pulmonary Drug Discovery
PremiumPrivate Companies
Insilico Medicine Draws Expert Interest in AI-Driven Pulmonary Drug Discovery
13d ago
INSIL
AI-Driven Drug Discovery Platform Highlighted in Pulmonary Clinical Trials Forum
PremiumPrivate CompaniesAI-Driven Drug Discovery Platform Highlighted in Pulmonary Clinical Trials Forum
14d ago
INSIL
Insilico Medicine Highlighted for ADA 2026 Oral Presentation on Diabetic Foot Ulcer Therapy
Premium
Private Companies
Insilico Medicine Highlighted for ADA 2026 Oral Presentation on Diabetic Foot Ulcer Therapy
15d ago
INSIL
Insilico Medicine Deepens AI Drug Discovery Credentials With Clinical, Partnership and Advocacy Moves
Premium
Private Companies
Insilico Medicine Deepens AI Drug Discovery Credentials With Clinical, Partnership and Advocacy Moves
16d ago
INSIL

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >